Annual report
8938.TEDINET S100TZJ2
Period2023-04-01 → 2024-03-31
Filed2024-07-03
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Amends S100TX4J. Amended by S100TZKY (2024-07-03).
Key figures · 142
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥1.2bn | 2023-04-01 → 2024-03-31 | Cons. | Net sales |
| Revenue | ¥1.8bn | 2022-04-01 → 2023-03-31 | Cons. | Net sales |
| Revenue | ¥2.5bn | 2021-04-01 → 2022-03-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥3.9bn | 2020-04-01 → 2021-03-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥8.3bn | 2019-04-01 → 2020-03-31d | Cons. | Net sales (5-year summary) |
| Operating income | −¥144m | 2023-04-01 → 2024-03-31 | Cons. | Operating income |
| Operating income | ¥89m | 2022-04-01 → 2023-03-31 | Cons. | Operating income |
| Ordinary income | −¥192m | 2023-04-01 → 2024-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥268m | 2022-04-01 → 2023-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥346m | 2021-04-01 → 2022-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥46m | 2020-04-01 → 2021-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | −¥2.2bn | 2019-04-01 → 2020-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | −¥184m | 2023-04-01 → 2024-03-31 | Cons. | Income before income taxes |
| Profit before tax | ¥390m | 2022-04-01 → 2023-03-31 | Cons. | Income before income taxes |
| Net income (owners) | −¥198m | 2023-04-01 → 2024-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥348m | 2022-04-01 → 2023-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥208m | 2021-04-01 → 2022-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | −¥255m | 2020-04-01 → 2021-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | −¥2.2bn | 2019-04-01 → 2020-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | −¥198m | 2023-04-01 → 2024-03-31 | Cons. | Profit loss |
| Net income | ¥350m | 2022-04-01 → 2023-03-31 | Cons. | Profit loss |
| Total assets | ¥8.4bn | at 2024-03-31 | Cons. | Assets |
| Total assets | ¥8.4bn | at 2023-03-31 | Cons. | Assets |
| Total assets | ¥8.9bn | at 2022-03-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥8.3bn | at 2021-03-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥11.1bn | at 2020-03-31d | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥593m | at 2024-03-31 | Cons. | Liabilities |
| Total liabilities | ¥426m | at 2023-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥7.8bn | at 2024-03-31 | Cons. | Net assets |
| Net assets / equity | ¥8.0bn | at 2023-03-31 | Cons. | Net assets |
| Net assets / equity | ¥7.7bn | at 2022-03-31d | Cons. | Net assets |
| Net assets / equity | ¥7.3bn | at 2021-03-31d | Cons. | Net assets (5-year summary) |
| Net assets / equity | ¥3.7bn | at 2020-03-31d | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥2.8bn | at 2024-03-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥3.0bn | at 2023-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥2.8bn | at 2024-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥3.0bn | at 2023-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.8bn | at 2022-03-31d | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥2.1bn | at 2021-03-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥945m | at 2020-03-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Operating cash flow | −¥187m | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥755m | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥196m | 2021-04-01 → 2022-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥2.7bn | 2020-04-01 → 2021-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥3.7bn | 2019-04-01 → 2020-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | ¥38m | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | ¥769m | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥172m | 2021-04-01 → 2022-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | ¥695m | 2020-04-01 → 2021-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | ¥1.3bn | 2019-04-01 → 2020-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | −¥45m | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥364m | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥276m | 2021-04-01 → 2022-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥2.2bn | 2020-04-01 → 2021-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥7.4bn | 2019-04-01 → 2020-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥-21.91 | 2023-04-01 → 2024-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥38.47 | 2022-04-01 → 2023-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥23.09 | 2021-04-01 → 2022-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-38.82 | 2020-04-01 → 2021-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-400.62 | 2019-04-01 → 2020-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥23.08 | 2021-04-01 → 2022-03-31d | Cons. | Diluted earnings per share (5-year summary) |
| Net assets per share | ¥840.79 | at 2024-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥867.29 | at 2023-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥835.41 | at 2022-03-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥811.66 | at 2021-03-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥669.37 | at 2020-03-31d | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 91.0% | at 2024-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 93.1% | at 2023-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 85.0% | at 2022-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 88.5% | at 2021-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 33.4% | at 2020-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| ROE | 4.5% | 2022-04-01 → 2023-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 2.8% | 2021-04-01 → 2022-03-31d | Cons. | Rate of return on equity (5-year summary) |
| Employees | 72 | at 2024-03-31 | Cons. | Number of employees |
| Employees | 61 | at 2023-03-31 | Cons. | Number of employees |
| Employees | 62 | at 2022-03-31d | Cons. | Number of employees |
| Employees | 48 | at 2021-03-31d | Cons. | Number of employees |
| Employees | 59 | at 2020-03-31d | Cons. | Number of employees |
| Revenue | ¥496m | 2023-04-01 → 2024-03-31 | Standalone | Net sales |
| Revenue | ¥150m | 2022-04-01 → 2023-03-31 | Standalone | Net sales |
| Revenue | ¥222m | 2021-04-01 → 2022-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥149m | 2020-04-01 → 2021-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥4.4bn | 2019-04-01 → 2020-03-31d | Standalone | Net sales (5-year summary) |
| Operating income | ¥23m | 2023-04-01 → 2024-03-31 | Standalone | Operating income |
| Operating income | −¥422m | 2022-04-01 → 2023-03-31 | Standalone | Operating income |
| Ordinary income | ¥24m | 2023-04-01 → 2024-03-31 | Standalone | Ordinary income |
| Ordinary income | −¥357m | 2022-04-01 → 2023-03-31 | Standalone | Ordinary income |
| Ordinary income | −¥380m | 2021-04-01 → 2022-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥1.1bn | 2020-04-01 → 2021-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | −¥1.5bn | 2019-04-01 → 2020-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥47m | 2023-04-01 → 2024-03-31 | Standalone | Income before income taxes |
| Profit before tax | −¥307m | 2022-04-01 → 2023-03-31 | Standalone | Income before income taxes |
| Net income | ¥45m | 2023-04-01 → 2024-03-31 | Standalone | Profit loss |
| Net income | −¥192m | 2022-04-01 → 2023-03-31 | Standalone | Profit loss |
| Net income | −¥125m | 2021-04-01 → 2022-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥1.1bn | 2020-04-01 → 2021-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | −¥2.4bn | 2019-04-01 → 2020-03-31d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥7.4bn | at 2024-03-31 | Standalone | Assets |
| Total assets | ¥7.4bn | at 2023-03-31 | Standalone | Assets |
| Total assets | ¥7.9bn | at 2022-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥7.9bn | at 2021-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥9.1bn | at 2020-03-31d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥269m | at 2024-03-31 | Standalone | Liabilities |
| Total liabilities | ¥256m | at 2023-03-31 | Standalone | Liabilities |
| Net assets / equity | ¥7.2bn | at 2024-03-31 | Standalone | Net assets |
| Net assets / equity | ¥7.2bn | at 2023-03-31 | Standalone | Net assets |
| Net assets / equity | ¥7.3bn | at 2022-03-31d | Standalone | Net assets |
| Net assets / equity | ¥7.4bn | at 2021-03-31d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥2.5bn | at 2020-03-31d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥2.2bn | at 2024-03-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥2.4bn | at 2023-03-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥5.02 | 2023-04-01 → 2024-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-21.23 | 2022-04-01 → 2023-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-13.85 | 2021-04-01 → 2022-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥172.86 | 2020-04-01 → 2021-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-432.87 | 2019-04-01 → 2020-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥5.02 | 2023-04-01 → 2024-03-31 | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥172.74 | 2020-04-01 → 2021-03-31d | Standalone | Diluted earnings per share (5-year summary) |
| Dividend per share | ¥5 | 2022-04-01 → 2023-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥6 | 2021-04-01 → 2022-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥773.91 | at 2024-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥773.9 | at 2023-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥801.13 | at 2022-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥814.98 | at 2021-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥456.78 | at 2020-03-31d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 94.2% | at 2024-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 94.4% | at 2023-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 91.9% | at 2022-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 93.6% | at 2021-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 28.1% | at 2020-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 0.6% | 2023-04-01 → 2024-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 22.9% | 2020-04-01 → 2021-03-31d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 9,051,000 | at 2024-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 9,051,000 | at 2023-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 9,051,000 | at 2022-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 9,051,000 | at 2021-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 5,560,400 | at 2020-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 16 | at 2024-03-31 | Standalone | Number of employees |
| Employees | 16 | at 2023-03-31 | Standalone | Number of employees |
| Employees | 15 | at 2022-03-31d | Standalone | Number of employees |
| Employees | 10 | at 2021-03-31d | Standalone | Number of employees |
| Employees | 19 | at 2020-03-31d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 46
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | segment profit | 2023-04-01 → 2024-03-31 | −¥365m |
| Company Widereportable segment | employees | at 2024-03-31 | 16 pure |
| Hospital Businessreportable segment | employees | at 2024-03-31 | 56 pure |
| Hospital Related Businessreportable segment | depreciation | 2023-04-01 → 2024-03-31 | ¥4m |
| Hospital Related Businessreportable segment | revenue | 2023-04-01 → 2024-03-31 | ¥1.1bn |
| Hospital Related Businessreportable segment | revenue external | 2023-04-01 → 2024-03-31 | ¥1.1bn |
| Hospital Related Businessreportable segment | segment assets | at 2024-03-31 | ¥6.8bn |
| Hospital Related Businessreportable segment | segment profit | 2023-04-01 → 2024-03-31 | ¥170m |
| Real Estate Businessreportable segment | depreciation | 2023-04-01 → 2024-03-31 | ¥61m |
| Real Estate Businessreportable segment | employees | at 2024-03-31 | 0 pure |
| Real Estate Businessreportable segment | revenue | 2023-04-01 → 2024-03-31 | ¥136m |
| Real Estate Businessreportable segment | revenue external | 2023-04-01 → 2024-03-31 | ¥136m |
| Real Estate Businessreportable segment | segment assets | at 2024-03-31 | ¥1.5bn |
| Real Estate Businessreportable segment | segment profit | 2023-04-01 → 2024-03-31 | ¥51m |
| —segment total | depreciation | 2023-04-01 → 2024-03-31 | ¥65m |
| —segment total | employees | at 2024-03-31 | 72 pure |
| —segment total | revenue | 2023-04-01 → 2024-03-31 | ¥1.2bn |
| —segment total | revenue external | 2023-04-01 → 2024-03-31 | ¥1.2bn |
| —segment total | segment assets | at 2024-03-31 | ¥8.4bn |
| —segment total | segment profit | 2023-04-01 → 2024-03-31 | ¥221m |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2023-04-01 → 2024-03-31 | ¥65m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2023-04-01 → 2024-03-31 | ¥1.2bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2023-04-01 → 2024-03-31 | ¥1.2bn |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2024-03-31 | ¥8.4bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2023-04-01 → 2024-03-31 | ¥221m |
| Reconciling Itemsreconciling | segment profit | 2022-04-01 → 2023-03-31 | −¥452m |
| Hospital Related Businessreportable segment | depreciation | 2022-04-01 → 2023-03-31 | ¥5m |
| Hospital Related Businessreportable segment | revenue | 2022-04-01 → 2023-03-31 | ¥1.1bn |
| Hospital Related Businessreportable segment | revenue external | 2022-04-01 → 2023-03-31 | ¥1.1bn |
| Hospital Related Businessreportable segment | segment assets | at 2023-03-31 | ¥7.0bn |
| Hospital Related Businessreportable segment | segment profit | 2022-04-01 → 2023-03-31 | ¥416m |
| Real Estate Businessreportable segment | depreciation | 2022-04-01 → 2023-03-31 | ¥76m |
| Real Estate Businessreportable segment | revenue | 2022-04-01 → 2023-03-31 | ¥712m |
| Real Estate Businessreportable segment | revenue external | 2022-04-01 → 2023-03-31 | ¥712m |
| Real Estate Businessreportable segment | segment assets | at 2023-03-31 | ¥1.5bn |
| Real Estate Businessreportable segment | segment profit | 2022-04-01 → 2023-03-31 | ¥124m |
| —segment total | depreciation | 2022-04-01 → 2023-03-31 | ¥81m |
| —segment total | revenue | 2022-04-01 → 2023-03-31 | ¥1.8bn |
| —segment total | revenue external | 2022-04-01 → 2023-03-31 | ¥1.8bn |
| —segment total | segment assets | at 2023-03-31 | ¥8.4bn |
| —segment total | segment profit | 2022-04-01 → 2023-03-31 | ¥541m |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2022-04-01 → 2023-03-31 | ¥81m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-04-01 → 2023-03-31 | ¥1.8bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-04-01 → 2023-03-31 | ¥1.8bn |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2023-03-31 | ¥8.4bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-04-01 → 2023-03-31 | ¥541m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,436
| Item | Context | Value | Unit |
|---|---|---|---|
| Independent auditors report consolidated (text) | FilingDateInstant | Text · Plus | |
| Audit firm1 consolidated | FilingDateInstant | Original text (Japanese)協立神明監査法人 | |
| Cpa1 audit firm1 consolidated | FilingDateInstant | Original text (Japanese)朝 田 潔 | |
| Cpa2 audit firm1 consolidated | FilingDateInstant | Original text (Japanese)田 中 伴 一 | |
| Key audit matters consolidated (text) | FilingDateInstant | Text · Plus | |
| Overview kam consolidated (text) | FilingDateInstant | Text · Plus | |
| Short description kam consolidated | FilingDateInstant_Row1Member | Original text (Japanese)医療関連セグメントにおける売掛金及び貸付金の評価の妥当性 | |
| Description including reason kam consolidated (text) | FilingDateInstant_Row1Member | Text · Plus | |
| Reference kam consolidated | FilingDateInstant_Row1Member | Original text (Japanese)（重要な会計上の見積り） | |
| Auditors response kam consolidated (text) | FilingDateInstant_Row1Member | Text · Plus | |
| Other information consolidated (text) | FilingDateInstant | Text · Plus | |
| Fee related information consolidated (text) | FilingDateInstant | Text · Plus | |
| Independent auditors report non consolidated (text) | FilingDateInstant | Text · Plus | |
| Audit firm1 non consolidated | FilingDateInstant | Original text (Japanese)協立神明監査法人 | |
| Cpa1 audit firm1 non consolidated | FilingDateInstant | Original text (Japanese)朝 田 潔 | |
| Cpa2 audit firm1 non consolidated | FilingDateInstant | Original text (Japanese)田 中 伴 一 | |
| Key audit matters non consolidated (text) | FilingDateInstant | Text · Plus | |
| Overview kam non consolidated (text) | FilingDateInstant | Text · Plus | |
| Short description kam non consolidated | FilingDateInstant_Row1Member | Original text (Japanese)医療関連セグメントにおける売掛金及び貸付金の評価の妥当性 | |
| Same as kam for consolidated fskam non consolidated (text) | FilingDateInstant_Row1Member | Text · Plus | |
| Other information non consolidated (text) | FilingDateInstant | Text · Plus | |
| Fee related information non consolidated (text) | FilingDateInstant | Text · Plus | |
| Number of submission | FilingDateInstant | 2 | |
| Net sales (5-year summary) | Prior4YearDuration | 8288000000 | JPY |
| Net sales (5-year summary) | Prior3YearDuration | 3904000000 | JPY |
| Net sales (5-year summary) | Prior2YearDuration | 2470000000 | JPY |
| Net sales (5-year summary) | Prior1YearDuration | 1798000000 | JPY |
| Net sales (5-year summary) | CurrentYearDuration | 1238000000 | JPY |
| Ordinary income loss (5-year summary) | Prior4YearDuration | -2219000000 | JPY |
| Ordinary income loss (5-year summary) | Prior3YearDuration | 46000000 | JPY |
| Ordinary income loss (5-year summary) | Prior2YearDuration | 346000000 | JPY |
| Ordinary income loss (5-year summary) | Prior1YearDuration | 268000000 | JPY |
| Ordinary income loss (5-year summary) | CurrentYearDuration | -192000000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | Prior4YearDuration | -2227000000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | Prior3YearDuration | -255000000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | Prior2YearDuration | 208000000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | Prior1YearDuration | 348000000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | CurrentYearDuration | -198000000 | JPY |
| Comprehensive income (5-year summary) | Prior4YearDuration | -2646000000 | JPY |
| Comprehensive income (5-year summary) | Prior3YearDuration | -75000000 | JPY |
| Comprehensive income (5-year summary) | Prior2YearDuration | 226000000 | JPY |
| Comprehensive income (5-year summary) | Prior1YearDuration | 345000000 | JPY |
| Comprehensive income (5-year summary) | CurrentYearDuration | -194000000 | JPY |
| Net assets (5-year summary) | Prior4YearInstant | 3708000000 | JPY |
| Net assets (5-year summary) | Prior3YearInstant | 7341000000 | JPY |
| Net assets (5-year summary) | Prior2YearInstant | 7656000000 | JPY |
| Net assets (5-year summary) | Prior1YearInstant | 8006000000 | JPY |
| Net assets (5-year summary) | CurrentYearInstant | 7768000000 | JPY |
| Total assets (5-year summary) | Prior4YearInstant | 11127000000 | JPY |
| Total assets (5-year summary) | Prior3YearInstant | 8303000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 24 of 24 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |